A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis.

Natasha StevensChigozie EzegbeValery Fuh-NgwaKalina MakowieckiAmin ZarghamiPhuong Tram NguyenJulie SansomKate SmithLaura L LaslettMeg DenhamCarlie L CullenMichael H BarnettMark R HinderMonique BreslinKaylene M YoungBruce V Taylor

Published in: Trials (2024)

Registered with Australian New Zealand Clinical Trials Registry, 20 January 2022; ACTRN12622000064707.

Keyphrases

transcranial magnetic stimulation
high frequency
multiple sclerosis
clinical trial
open label
phase ii
white matter
randomized controlled trial
study protocol
phase iii